Kala Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
KALA
CUSIP
483119103
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 2 154 $561.00
2024 Q4 1 1.00 $7.00
2024 Q3 1 1.00 $6.00
2024 Q2 1 1.00 $7.00
2024 Q1 1 1.00 $8.00
2023 Q4 1 1.00 $7.00
2023 Q3 1 1.00 $9.00
2023 Q2 3 106 $1.55 k
2023 Q1 2 11.0 $166.00
2022 Q4 3 12.0 k $459 k
2022 Q3 57 6.07 M $1.34 M
2022 Q2 74 7.58 M $2.27 M
2022 Q1 93 24.4 M $33.7 M
2021 Q4 93 25.7 M $31.1 M
2021 Q3 117 30.3 M $79.6 M
2021 Q2 119 32.3 M $171 M
2021 Q1 134 37.0 M $249 M
2020 Q4 140 38.0 M $257 M
2020 Q3 131 38.1 M $286 M
2020 Q2 145 43.0 M $452 M
2020 Q1 112 40.2 M $353 M
2019 Q4 80 22.4 M $82.5 M
2019 Q3 75 22.2 M $84.5 M
2019 Q2 76 23.4 M $149 M
2019 Q1 80 23.7 M $196 M
2018 Q4 78 23.2 M $113 M
2018 Q3 78 16.2 M $160 M
2018 Q2 74 18.1 M $248 M
2018 Q1 77 19.0 M $301 M
2017 Q4 64 17.7 M $328 M
2017 Q3 60 15.5 M $353 M